Hepatitis B

Chronic hepatitis B virus (HBV) infection is a leading cause of cirrhosis and liver cancer worldwide; [1] the estimated prevalence in the United States is 0.3%–0.5%. [2] Each year, approximately 11,500–13,000 persons are newly reported with ...  

LITTLE ROCK (KTHV)-- A restaurant can be a breeding ground for hepatitis A. Out of the liver viruses of hep. A,B and C, UAMS internist Dr. Robert Hopkins says, it's the more common of the bunch. He says, "Hepatitis A is transmitted by contaminated food or water.  

Local health officials urge diabetics to get the Hepatitis B vaccine. The Cerro Gordo County Department of Public Health wants diabetics to know about some new recommendations. The Advisory Committee on Immunization Practices is now recommending diabetics ...  

On Feb. 1, the White House Initiative on Asian Americans and Pacific Islanders expressed their commitment to ending viral hepatitis nationwide. 1 in 12 people worldwide is living with viral hepatitis, with viral hepatitis affecting as many as 5 million Americans. Hepatitis B affects 1 in...  

'THE SILENT KILLER': An estimated 4.4million Americans are living with some form of chronic hepatitis. Most do not know they are infected. About 80,000 new infections occur each year. "Hepatitis" means inflammation of the liver and also refers to a group of viral infections that affect the liver. The Hepatitis B virus (HBV) is often called "the silent killer" because many people have no symptoms, so the disease often progresses unnoticed for...  

The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule published February 1 in Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP). In addition to the changes in the HPV vaccine, the ACIP now...  

VIROLOGY: How to prevent hepatitis B virus reproducing Infection with hepatitis B virus (HBV) is a major health problem worldwide, despite the fact that a highly effective preventative vaccine exists. A modified form of the immune molecule IFN-alpha is commonly used to treat individuals infected with HBV. The rationale behind this is that IFN-alpha inhibits HBV replication in vivo and in vitro, although the mechanisms by which it does this...  

Mendocino County's AIDS/Viral Hepatitis Network, or MCAVN, will host its 25th annual fundraising benefit, Event of the Heart, this Saturday, February 11, at the Ukiah Valley Conference Center. MCAVN provides services to the community by caring for those living with, affected by, or at risk of AIDS or viral hepatitis by reducing harmful practices and promoting healthy lifestyles.  

To access the live audio webcast of the presentation ... SciClone's ZADAXIN® (thymalfasin) is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers according ...  

Combination therapy with pegylated interferon (PEG-IFN) and ribavirin long stood as the standard of care for chronic hepatitis C virus (HCV) infection. Although effective in achieving high rates of sustained virologic response (SVR), this ...  

HealthDay - THURSDAY, Jan. 26 (HealthDay News) -- Popular cholesterol-lowering statins may also lower risk for liver cancer among people with hepatitis B, a new study shows. Hepatitis B, an inflammation of the liver due to the hepatitis B virus, is one of the main causes of liver cancer.  

FOSTER CITY, Calif. (TheStreet) --Gilead Sciences surprised investors Thursday night with exciting new data from its lead hepatitis C drug that overshadowed a disappointing fourth-quarter earnings and weaker-than-expected guidance for the coming year. On Gilead's quarterly conference call, the company's research chief disclosed that all genotype 1 hepatitis C patients treated with the experimental pill GS-7977 plus ribavirin had no evidence...  

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis. This finding by Dr. Samuel  

Summary.  The chemokine monokine induced by interferon-γ (Mig) is involved in the recruitment of inflammatory cells and liver injury during hepatitis B virus (HBV) infection. HBV protein X contributes to Mig expression in vitro by activation of  

It wasn’t long ago when the diagnosis of Hepatitis C meant a great deal of uncertainty. Physicians struggled to find an effective treatment of this infection. Patients faced the possibility of developing cirrhosis of the liver and even the chance of ...